Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Novartis
Moodys
Chubb
McKesson
Cipla
Medtronic
Healthtrust
US Army
Mallinckrodt

Generated: December 12, 2017

DrugPatentWatch Database Preview

KADIAN Drug Profile

« Back to Dashboard

When do Kadian patents expire, and what generic alternatives are available?

Kadian is a drug marketed by Allergan Sales Llc and is included in one NDA.

The generic ingredient in KADIAN is morphine sulfate. There are twenty-three drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.
Drug patent expirations by year for KADIAN

Pharmacology for KADIAN

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists

Medical Subject Heading (MeSH) Categories for KADIAN

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Allergan Sales LlcKADIANmorphine sulfateCAPSULE, EXTENDED RELEASE;ORAL020616-008Apr 20, 2007ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Allergan Sales LlcKADIANmorphine sulfateCAPSULE, EXTENDED RELEASE;ORAL020616-010Jul 9, 2012ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Allergan Sales LlcKADIANmorphine sulfateCAPSULE, EXTENDED RELEASE;ORAL020616-009Jul 9, 2012ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Allergan Sales LlcKADIANmorphine sulfateCAPSULE, EXTENDED RELEASE;ORAL020616-007Feb 27, 2007RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Allergan Sales LlcKADIANmorphine sulfateCAPSULE, EXTENDED RELEASE;ORAL020616-006Oct 27, 2006ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Allergan Sales LlcKADIANmorphine sulfateCAPSULE, EXTENDED RELEASE;ORAL020616-001Jul 3, 1996ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Allergan Sales LlcKADIANmorphine sulfateCAPSULE, EXTENDED RELEASE;ORAL020616-004Mar 9, 2001ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Allergan Sales LlcKADIANmorphine sulfateCAPSULE, EXTENDED RELEASE;ORAL020616-005Mar 9, 2001ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Allergan Sales LlcKADIANmorphine sulfateCAPSULE, EXTENDED RELEASE;ORAL020616-002Jul 3, 1996ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Allergan Sales LlcKADIANmorphine sulfateCAPSULE, EXTENDED RELEASE;ORAL020616-011Jul 9, 2012RXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: KADIAN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan Sales LlcKADIANmorphine sulfateCAPSULE, EXTENDED RELEASE;ORAL020616-002Jul 3, 1996► Subscribe► Subscribe
Allergan Sales LlcKADIANmorphine sulfateCAPSULE, EXTENDED RELEASE;ORAL020616-007Feb 27, 2007► Subscribe► Subscribe
Allergan Sales LlcKADIANmorphine sulfateCAPSULE, EXTENDED RELEASE;ORAL020616-006Oct 27, 2006► Subscribe► Subscribe
Allergan Sales LlcKADIANmorphine sulfateCAPSULE, EXTENDED RELEASE;ORAL020616-008Apr 20, 2007► Subscribe► Subscribe
Allergan Sales LlcKADIANmorphine sulfateCAPSULE, EXTENDED RELEASE;ORAL020616-002Jul 3, 1996► Subscribe► Subscribe
Allergan Sales LlcKADIANmorphine sulfateCAPSULE, EXTENDED RELEASE;ORAL020616-003Jul 3, 1996► Subscribe► Subscribe
Allergan Sales LlcKADIANmorphine sulfateCAPSULE, EXTENDED RELEASE;ORAL020616-005Mar 9, 2001► Subscribe► Subscribe
Allergan Sales LlcKADIANmorphine sulfateCAPSULE, EXTENDED RELEASE;ORAL020616-004Mar 9, 2001► Subscribe► Subscribe
Allergan Sales LlcKADIANmorphine sulfateCAPSULE, EXTENDED RELEASE;ORAL020616-001Jul 3, 1996► Subscribe► Subscribe
Allergan Sales LlcKADIANmorphine sulfateCAPSULE, EXTENDED RELEASE;ORAL020616-005Mar 9, 2001► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Queensland Health
Colorcon
McKesson
Baxter
Deloitte
Harvard Business School
Novartis
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot